The New Jersey Cannabis Regulatory Commission is seeking comments from the public on proposed regulations to expand ingestible cannabis products. During the comment period – October 16 to December 15, 2023 – the Commission is inviting the public, industry stakeholders, and interested parties to submit their feedback on the proposed rules.
The Jake Honig Compassionate Use Medical Cannabis Act provides the framework for the medicinal use of cannabis in New Jersey. The Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization (CREAMM) Act does the same for recreational use and includes the establishment of the Cannabis Regulatory Commission. The Personal-Use Cannabis Rules (N.J.A.C 17:30) were last updated/amended effective March 6, 2023.
The proposed rules for cannabis products include several key components:
- The products can contain ingredients that the FDA generally recognizes as safe (GRAS)
- Products manufactured under the proposed regulations (and regulatory waivers) cannot contain alcohol, tobacco, nicotine or any controlled dangerous substance
- The products must be shelf-stable or non-time/temperature control for safety (non-TCS)
- The products cannot require further cooking or baking by consumer, or storage in sterile environments
- Businesses and employees must comply with food safety regulations and good manufacturing practices (GPS) when manufacturing cannabis items
In order to submit a comment on the proposed rules for the expansion of edible cannabis products, click here.
